Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line

Jacob Bornstein, Shlomi Sagi, Amer Haj, Jeffrey Harroch, Fuad Fares

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective. To determine whether Arsenic Trioxide may be an effective treatment of human ovarian carcinoma, we examined if it induced apoptosis in human ovarian cancer cell line. Methods. The human ovarian cell line SKOV3 was exposed to different concentrations of As2O3: 0 (control), 0.1 μM, 1 μM, 5 μM and 10 μM. The effect on cells proliferation and apoptotic parameters was examined. Results. The most effective inhibitory Arsenic Trioxide concentrations were 5 μM and 10 μM, causing growth inhibition of 79% and 83%, respectively. The maximum inhibitory effect of Arsenic Trioxide on cellular proliferation was seen after 48 h. No morphological or molecular features of apoptosis have been observed. At the same time, there were no typical changes of cellular necrosis. Conclusions. The exact mechanism by which Arsenic Trioxide inhibits the growth of ovarian cancer cells is probably not by apoptosis. However, since As2O3 has been shown to inhibit ovarian cancer cellular growth, it should be further elucidated as a possible chemotherapeutic agent of ovarian cancer.

Original languageEnglish
Pages (from-to)726-729
Number of pages4
JournalGynecologic Oncology
Volume99
Issue number3
DOIs
StatePublished - Dec 1 2005

Fingerprint

Carcinoma
Cell Line
Ovarian Neoplasms
Growth
Apoptosis
Cell Proliferation
arsenic trioxide
Necrosis

Keywords

  • Chemotherapy
  • Cytotoxic agent
  • Female
  • Human neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line. / Bornstein, Jacob; Sagi, Shlomi; Haj, Amer; Harroch, Jeffrey; Fares, Fuad.

In: Gynecologic Oncology, Vol. 99, No. 3, 01.12.2005, p. 726-729.

Research output: Contribution to journalArticle

Bornstein, J, Sagi, S, Haj, A, Harroch, J & Fares, F 2005, 'Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line', Gynecologic Oncology, vol. 99, no. 3, pp. 726-729. https://doi.org/10.1016/j.ygyno.2005.07.125
Bornstein, Jacob ; Sagi, Shlomi ; Haj, Amer ; Harroch, Jeffrey ; Fares, Fuad. / Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line. In: Gynecologic Oncology. 2005 ; Vol. 99, No. 3. pp. 726-729.
@article{0841a6363bd347f695e96f97b2491a19,
title = "Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line",
abstract = "Objective. To determine whether Arsenic Trioxide may be an effective treatment of human ovarian carcinoma, we examined if it induced apoptosis in human ovarian cancer cell line. Methods. The human ovarian cell line SKOV3 was exposed to different concentrations of As2O3: 0 (control), 0.1 μM, 1 μM, 5 μM and 10 μM. The effect on cells proliferation and apoptotic parameters was examined. Results. The most effective inhibitory Arsenic Trioxide concentrations were 5 μM and 10 μM, causing growth inhibition of 79{\%} and 83{\%}, respectively. The maximum inhibitory effect of Arsenic Trioxide on cellular proliferation was seen after 48 h. No morphological or molecular features of apoptosis have been observed. At the same time, there were no typical changes of cellular necrosis. Conclusions. The exact mechanism by which Arsenic Trioxide inhibits the growth of ovarian cancer cells is probably not by apoptosis. However, since As2O3 has been shown to inhibit ovarian cancer cellular growth, it should be further elucidated as a possible chemotherapeutic agent of ovarian cancer.",
keywords = "Chemotherapy, Cytotoxic agent, Female, Human neoplasms",
author = "Jacob Bornstein and Shlomi Sagi and Amer Haj and Jeffrey Harroch and Fuad Fares",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/j.ygyno.2005.07.125",
language = "English",
volume = "99",
pages = "726--729",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line

AU - Bornstein, Jacob

AU - Sagi, Shlomi

AU - Haj, Amer

AU - Harroch, Jeffrey

AU - Fares, Fuad

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Objective. To determine whether Arsenic Trioxide may be an effective treatment of human ovarian carcinoma, we examined if it induced apoptosis in human ovarian cancer cell line. Methods. The human ovarian cell line SKOV3 was exposed to different concentrations of As2O3: 0 (control), 0.1 μM, 1 μM, 5 μM and 10 μM. The effect on cells proliferation and apoptotic parameters was examined. Results. The most effective inhibitory Arsenic Trioxide concentrations were 5 μM and 10 μM, causing growth inhibition of 79% and 83%, respectively. The maximum inhibitory effect of Arsenic Trioxide on cellular proliferation was seen after 48 h. No morphological or molecular features of apoptosis have been observed. At the same time, there were no typical changes of cellular necrosis. Conclusions. The exact mechanism by which Arsenic Trioxide inhibits the growth of ovarian cancer cells is probably not by apoptosis. However, since As2O3 has been shown to inhibit ovarian cancer cellular growth, it should be further elucidated as a possible chemotherapeutic agent of ovarian cancer.

AB - Objective. To determine whether Arsenic Trioxide may be an effective treatment of human ovarian carcinoma, we examined if it induced apoptosis in human ovarian cancer cell line. Methods. The human ovarian cell line SKOV3 was exposed to different concentrations of As2O3: 0 (control), 0.1 μM, 1 μM, 5 μM and 10 μM. The effect on cells proliferation and apoptotic parameters was examined. Results. The most effective inhibitory Arsenic Trioxide concentrations were 5 μM and 10 μM, causing growth inhibition of 79% and 83%, respectively. The maximum inhibitory effect of Arsenic Trioxide on cellular proliferation was seen after 48 h. No morphological or molecular features of apoptosis have been observed. At the same time, there were no typical changes of cellular necrosis. Conclusions. The exact mechanism by which Arsenic Trioxide inhibits the growth of ovarian cancer cells is probably not by apoptosis. However, since As2O3 has been shown to inhibit ovarian cancer cellular growth, it should be further elucidated as a possible chemotherapeutic agent of ovarian cancer.

KW - Chemotherapy

KW - Cytotoxic agent

KW - Female

KW - Human neoplasms

UR - http://www.scopus.com/inward/record.url?scp=28044460481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044460481&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2005.07.125

DO - 10.1016/j.ygyno.2005.07.125

M3 - Article

VL - 99

SP - 726

EP - 729

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -